Atea Pharmaceuticals, Inc. (AVIR)
5.18
+0.20
(+4.02%)
USD |
NASDAQ |
Mar 05, 14:16
Atea Pharmaceuticals Cash from Investing (TTM) : 138.83M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Oramed Pharmaceuticals, Inc. | 23.22M |
| Aclaris Therapeutics, Inc. | 48.36M |
| PMV Pharmaceuticals, Inc. | 59.47M |
| Instil Bio, Inc. | 30.66M |
| Coya Therapeutics, Inc. | -0.516M |